Skip to main content

Advertisement

Log in

An update on the CNS manifestations of brain tumor polyposis syndromes

  • Review
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Cancer predisposition syndromes are associated with an increased risk of developing primary malignancies. Here we discuss those which are associated with an increased risk of tumors of the central nervous system (CNS) and gastrointestinal (GI) tract. These can be grouped into those in which the CNS tumors predominate versus those in which the GI cancers predominate. The former include constitutional mismatch repair deficiency (CMMRD) syndrome, Li–Fraumeni syndrome (LFS), and Cowden syndrome (CS) while the latter include familial adenomatosis polyposis 1 (FAP1), Lynch syndrome and polymerase proofreading-associated polyposis syndrome (PPAP). Tumor specificity does exist as medulloblastoma occur in FAP, LFS and CMMRD while glioma are most commonly seen in all replication repair-deficient genes and LFS. Choroid plexus carcinoma is strictly observed in LFS while Cowden syndrome patients develop Lhermitte Duclos disease or meningioma. In each syndrome, specific types of low-grade and high-grade gastrointestinal cancers can occur, but these will be discussed elsewhere. Underlying cancer predisposition syndromes are important to consider when faced with brain tumors, particularly in the pediatric and young adult age groups, as identification of an underlying germ line mutation may change the upfront management of the patient and has implications for future cancer surveillance for both the patient and potentially affected family members. Considerations of family history, presence of skin lesions and consanguinity provide valuable information in identifying patients at potential increased risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Abedalthagafi M (2018) Constitutional mismatch repair-deficiency: current problems and emerging therapeutic strategies. Oncotarget 9:35458–35469. https://doi.org/10.18632/oncotarget.26249

  2. Abel TW, Baker SJ, Fraser MM, Tihan T, Nelson JS, Yachnis AT et al (2005) Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway. J Neuropathol Exp Neurol 64:341–349. https://doi.org/10.1093/jnen/64.4.341

    Article  PubMed  Google Scholar 

  3. Aihara H, Tajiri H, Schneider M, Charton J-P, Neuhaus H (2014) Colon Capsule endoscopy in screening and surveillance for polyps and cancers. In: Keuchel M, Hagenmüller F, Tajiri H (eds) Video capsule endoscopy: a reference guide and atlas. Springer, Berlin, Heidelberg, pp 495–505

    Chapter  Google Scholar 

  4. Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Ng AW, Boot A et al (2018) The Repertoire of Mutational Signatures in Human Cancer. Biorxiv. https://doi.org/10.1101/322859

    Article  Google Scholar 

  5. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SAJR, Behjati S, Biankin AV et al (2013) Signatures of mutational processes in human cancer. Nature 500:415–421. https://doi.org/10.1038/nature12477

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. AlSalameh A, François P, Giraud S, Calender A, Bergemer-Fouquet AM, de Calan L et al (2010) Intracranial ependymoma associated with multiple endocrine neoplasia type 1. J Endocrinol Invest 33:353–356. https://doi.org/10.1007/BF03346599

    Article  CAS  Google Scholar 

  7. Amayiri N, Tabori U, Campbell B, Bakry D, Aronson M, Durno C et al (2016) High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan. Int J Cancer 138:380–385. https://doi.org/10.1002/ijc.29724

    Article  CAS  PubMed  Google Scholar 

  8. Bakry D, Aronson M, Durno C, Rimawi H, Farah R, Alharbi QK et al (1990) (2014) Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. Eur J Cancer Oxf Engl 50:987–996. https://doi.org/10.1016/j.ejca.2013.12.005

    Article  Google Scholar 

  9. Ballinger ML, Mitchell G, Thomas DM (2015) Surveillance recommendations for patients with germline TP53 mutations. Curr Opin Oncol 27:332–337. https://doi.org/10.1097/CCO.0000000000000200

    Article  CAS  PubMed  Google Scholar 

  10. Barel D, Avigad S, Mor C, Fogel M, Cohen IJ, Zaizov R (1998) A Novel Germ-line mutation in the noncoding region of the p53 gene in a Li–Fraumeni family. Cancer Genet Cytogenet 103:1–6. https://doi.org/10.1016/S0165-4608(97)00258-6

    Article  CAS  PubMed  Google Scholar 

  11. Blumenthal GM, Dennis PA (2008) PTEN hamartoma tumor syndromes. Eur J Hum Genet EJHG 16:1289–1300. https://doi.org/10.1038/ejhg.2008.162

    Article  CAS  PubMed  Google Scholar 

  12. Bodo S, Colas C, Buhard O, Collura A, Tinat J, Lavoine N et al (2015) Diagnosis of constitutional mismatch repair-deficiency syndrome based on microsatellite instability and lymphocyte tolerance to methylating agents. Gastroenterology 149:1017–1029.e3. https://doi.org/10.1053/j.gastro.2015.06.013

    Article  PubMed  Google Scholar 

  13. Bouffet E, Larouche V, Campbell BB, Merico D, Borja RD, Aronson M et al (2016) Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency. J Clin Oncol 34:2206–2211. https://doi.org/10.1200/JCO.2016.66.6552

    Article  CAS  PubMed  Google Scholar 

  14. Buchanan DD, Stewart JR, Clendenning M, Rosty C, Mahmood K, Pope BJ et al (2018) Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1. Genet Med 20:890. https://doi.org/10.1038/gim.2017.185

    Article  CAS  PubMed  Google Scholar 

  15. Burt RW, Cannon JA, David DS, Early DS, Ford JM, Giardiello FM et al (2013) Colorectal cancer screening. J Natl Compr Canc Netw 11:1538–1575. https://doi.org/10.6004/jnccn.2013.0180

    Article  CAS  PubMed  Google Scholar 

  16. Bussey HJR (1975) Familial polyposis coli: family studies, histopathology, differential diagnosis, and results of treatment. Johns Hopkins University Press, Baltimore

    Google Scholar 

  17. Campbell BB, Light N, Fabrizio D, Zatzman M, Fuligni F, de Borja R et al (2017) Comprehensive analysis of hypermutation in human cancer. Cell 171:1042–1056.e10. https://doi.org/10.1016/j.cell.2017.09.048

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Chang DK, Ricciardiello L, Goel A, Chang CL, Boland CR (2000) Steady-state regulation of the human DNA mismatch repair system. J Biol Chem 275:18424–18431. https://doi.org/10.1074/jbc.M001140200

    Article  CAS  PubMed  Google Scholar 

  19. Chapelle A (2005) The incidence of Lynch syndrome. Fam Cancer 4:233–237. https://doi.org/10.1007/s10689-004-5811-3

    Article  PubMed  Google Scholar 

  20. Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K et al (2006) Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296:1479–1487. https://doi.org/10.1001/jama.296.12.1479

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Cohen SA, Leininger A (2014) The genetic basis of Lynch syndrome and its implications for clinical practice and risk management. Appl Clin Genet 7:147–158. https://doi.org/10.2147/TACG.S51483

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Cuevas-Ocampo AK, Bollen AW, Goode B, Pajtler KW, Chavez L, Sharma T et al (2017) Genetic confirmation that ependymoma can arise as part of multiple endocrine neoplasia type 1 (MEN1) syndrome. Acta Neuropathol (Berl) 133:661–663. https://doi.org/10.1007/s00401-017-1689-7

    Article  Google Scholar 

  23. Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S et al (2017) NCCN guidelines insights: genetic/familial high-risk assessment: breast and ovarian, version 2.2017. J Natl Compr Cancer Netw JNCCN 15:9–20

    Article  CAS  Google Scholar 

  24. Devroede G, Lemieux B, Massé S, Lamarche J, Herman PS (1988) Colonic hamartomas in tuberous sclerosis. Gastroenterology 94:182–188. https://doi.org/10.1016/0016-5085(88)90628-2

    Article  CAS  PubMed  Google Scholar 

  25. Durno CA, Aronson M, Tabori U, Malkin D, Gallinger S, Chan HSL (2012) Oncologic surveillance for subjects with biallelic mismatch repair gene mutations: 10 year follow-up of a kindred. Pediatr Blood Cancer 59:652–656. https://doi.org/10.1002/pbc.24019

    Article  PubMed  Google Scholar 

  26. Durno CA, Sherman PM, Aronson M, Malkin D, Hawkins C, Bakry D et al (2015) Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome. Eur J Cancer Oxf Engl 51:977–983. https://doi.org/10.1016/j.ejca.2015.02.008

    Article  CAS  Google Scholar 

  27. Elsayed FA, Kets CM, Ruano D, van den Akker B, Mensenkamp AR, Schrumpf M et al (2015) Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer. Eur J Hum Genet 23:1080–1084. https://doi.org/10.1038/ejhg.2014.242

    Article  CAS  PubMed  Google Scholar 

  28. Erson-Omay EZ, Çağlayan AO, Schultz N, Weinhold N, Omay SB, Özduman K et al (2015) Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis. Neuro-Oncol 17:1356–1364. https://doi.org/10.1093/neuonc/nov027

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Funayama T, Sakane M, Yoshizawa T, Takeuchi Y, Ochiai N (2013) Tanycytic ependymoma of the filum terminale associated with multiple endocrine neoplasia type 1: first reported case. Spine J 13:e49–e54. https://doi.org/10.1016/j.spinee.2013.02.066

    Article  PubMed  Google Scholar 

  30. Gardner EJ, Richards RC (1953) Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 5:139–147

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Guha A, Glowacka D, Carroll R, Dashner K, Black PM, Stiles CD (1995) Expression of platelet derived growth factor and platelet derived growth factor receptor mRNA in a glioblastoma from a patient with Li–Fraumeni syndrome. J Neurol Neurosurg Psychiatry 58:711–714

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Gylling AHS, Nieminen TT, Abdel-Rahman WM, Nuorva K, Juhola M, Joensuu EI et al (2008) Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors. Carcinogenesis 29:1351–1359. https://doi.org/10.1093/carcin/bgn133

    Article  CAS  PubMed  Google Scholar 

  33. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM et al (1995) The molecular basis of Turcot’s syndrome. N Engl J Med 332:839–847. https://doi.org/10.1056/NEJM199503303321302

    Article  CAS  PubMed  Google Scholar 

  34. Heald B, Mester J, Rybicki L, Orloff MS, Burke CA, Eng C (2010) Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology 139:1927–1933. https://doi.org/10.1053/j.gastro.2010.06.061

    Article  CAS  PubMed  Google Scholar 

  35. Hisada M, Garber JE, Fung CY, Fraumeni JF, Li FP (1998) Multiple primary cancers in families with Li–Fraumeni syndrome. J Natl Cancer Inst 90:606–611. https://doi.org/10.1093/jnci/90.8.606

    Article  CAS  PubMed  Google Scholar 

  36. Hobert JA, Eng C (2009) PTEN hamartoma tumor syndrome: an overview. Genet Med 11:687–694. https://doi.org/10.1097/GIM.0b013e3181ac9aea

    Article  CAS  PubMed  Google Scholar 

  37. Jasperson KW, Patel SG, Ahnen DJ (1993) APC-associated polyposis conditions. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, Amemiya A (eds) GeneReviews®. University of Washington Seattle, Seattle.

  38. Kempers MJ, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, Rahner N et al (2011) Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol 12:49–55. https://doi.org/10.1016/S1470-2045(10)70265-5

    Article  PubMed  Google Scholar 

  39. Kovacs ME, Papp J, Szentirmay Z, Otto S, Olah E (2009) Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome. Hum Mutat 30:197–203. https://doi.org/10.1002/humu.20942

    Article  CAS  PubMed  Google Scholar 

  40. Krishnamurthy N, Kurzrock R (2018) Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev 62:50–60. https://doi.org/10.1016/j.ctrv.2017.11.002

    Article  CAS  PubMed  Google Scholar 

  41. Krutilkova V, Trkova M, Fleitz J, Gregor V, Novotna K, Krepelova A et al (2005) Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. Eur J Cancer 41:1597–1603. https://doi.org/10.1016/j.ejca.2005.01.026

    Article  CAS  PubMed  Google Scholar 

  42. Lachlan KL, Lucassen AM, Bunyan D, Temple IK (2007) Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet 44:579–585. https://doi.org/10.1136/jmg.2007.049981

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Lavoine N, Colas C, Muleris M, Bodo S, Duval A, Entz-Werle N et al (2015) Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort. J Med Genet 52:770–778. https://doi.org/10.1136/jmedgenet-2015-103299

    Article  CAS  PubMed  Google Scholar 

  44. Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD et al (2015) PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372:2509–2520. https://doi.org/10.1056/NEJMoa1500596

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Leoz ML, Carballal S, Moreira L, Ocaña T, Balaguer F (2015) The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management. Appl Clin Genet 8:95–107. https://doi.org/10.2147/TACG.S51484

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Li FP (1969) Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome? Ann Intern Med 71:747. https://doi.org/10.7326/0003-4819-71-4-747

    Article  CAS  PubMed  Google Scholar 

  47. Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA et al (1988) A cancer family syndrome in 24 kindreds. Cancer Res 48:5358–5362

    CAS  PubMed  Google Scholar 

  48. Li J, Woods SL, Healey S, Beesley J, Chen X, Lee JS et al (2016) Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Hum Genet 98:830–842. https://doi.org/10.1016/j.ajhg.2016.03.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z et al (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64. https://doi.org/10.1038/ng0597-64

    Article  CAS  PubMed  Google Scholar 

  50. Lindor NM, McMaster ML, Lindor CJ, Greene MH (2008) Concise handbook of familial cancer susceptibility syndromes—second edition. J Natl Cancer Inst Monogr. https://doi.org/10.1093/jncimonographs/lgn001

    Article  PubMed  Google Scholar 

  51. Lloyd KM (1963) Cowden’s disease: a possible new symptom complex with multiple system involvement. Ann Intern Med 58:136. https://doi.org/10.7326/0003-4819-58-1-136

    Article  PubMed  Google Scholar 

  52. Lynch ED, Ostermeyer EA, Lee MK, Arena JF, Ji H, Dann J et al (1997) Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis. Am J Hum Genet 61:1254–1260. https://doi.org/10.1086/301639

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC et al (1992) Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 326:1309–1315. https://doi.org/10.1056/NEJM199205143262002

    Article  CAS  PubMed  Google Scholar 

  54. Marsh DJ, Trahair TN, Martin JL, Chee WY, Walker J, Kirk EP et al (2008) Rapamycin treatment for a child with germline PTEN mutation. Nat Clin Pract Oncol 5:357–361. https://doi.org/10.1038/ncponc1112

    Article  CAS  PubMed  Google Scholar 

  55. Menko FH, Kaspers GL, Meijer GA, Claes K, van Hagen JM, Gille JJP (2004) A homozygous MSH6 mutation in a child with Café-au-Lait spots, oligodendroglioma and rectal cancer. Fam Cancer 3:123–127. https://doi.org/10.1023/B:FAME.0000039893.19289.18

    Article  CAS  PubMed  Google Scholar 

  56. Miyaki M, Nishio J, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M et al (1997) Drastic genetic instability of tumors and normal tissues in Turcot syndrome. Oncogene 15:2877–2881. https://doi.org/10.1038/sj.onc.1201668

    Article  CAS  PubMed  Google Scholar 

  57. NCCN (2018) National Comprehensive Cancer Network guidelines for colorectal cancer screening. National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdf. Accessed 4 June 2019

  58. Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR et al (1996) Localization of the gene for Cowden disease to chromosome 10q22–23. Nat Genet 13:114–116. https://doi.org/10.1038/ng0596-114

    Article  CAS  PubMed  Google Scholar 

  59. Nicolaides NC, Papadopoulos N, Liu B, Weit Y-F, Carter KC, Ruben SM et al (1994) Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer. Nature 371:75–80. https://doi.org/10.1038/371075a0

    Article  CAS  PubMed  Google Scholar 

  60. Northcott PA, Jones DT, Kool M, Robinson GW, Gilbertson RJ, Cho Y-J et al (2012) Medulloblastomics: the end of the beginning. Nat Rev Cancer 12:818–834. https://doi.org/10.1038/nrc3410

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P et al (2003) Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 63:6643–6650

    CAS  PubMed  Google Scholar 

  62. Ou J, Rasmussen M, Westers H, Andersen SD, Jager PO, Kooi KA et al (2009) Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome. Genes Chromosomes Cancer 48:340–350. https://doi.org/10.1002/gcc.20644

    Article  CAS  PubMed  Google Scholar 

  63. Palles C, Cazier J-B, Howarth KM, Domingo E, Jones AM, Broderick P et al (2013) Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet 45:136–144. https://doi.org/10.1038/ng.2503

    Article  CAS  PubMed  Google Scholar 

  64. Papadopoulos N, Lindblom A (1997) Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 10:89–99. https://doi.org/10.1002/(SICI)1098-1004(1997)10:2%3c89:AID-HUMU1%3e3.0.CO;2-H

    Article  CAS  PubMed  Google Scholar 

  65. Pietsch T, Haberler C (2016) Update on the integrated histopathological and genetic classification of medulloblastoma—a practical diagnostic guideline. Clin Neuropathol 35:344–352. https://doi.org/10.5414/NP300999

    Article  PubMed  PubMed Central  Google Scholar 

  66. Rao TP, Kühl M (2010) An updated overview on wnt signaling pathways. Circ Res 106:1798–1806. https://doi.org/10.1161/CIRCRESAHA.110.219840

    Article  CAS  PubMed  Google Scholar 

  67. Rausch T, Jones DTW, Zapatka M, Stütz AM, Zichner T, Weischenfeldt J et al (2012) Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148:59–71. https://doi.org/10.1016/j.cell.2011.12.013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Rieske P, Zakrzewska M, Biernat W, Bartkowiak J, Zimmermann A, Piotr-Liberski P (2005) Atypical molecular background of glioblastoma and meningioma developed in a patient with Li–Fraumeni syndrome. J Neurooncol 71:27–30. https://doi.org/10.1007/s11060-004-9181-3

    Article  CAS  PubMed  Google Scholar 

  69. Rosner G, Elya R, Bercovich D, Santo E, Halpern Z, Kariv R (2015) Mutations in DNA Polymerase Genes (POLD1 and POLE) in Individuals having early-onset colorectal cancer and/or multiple adenomas. Gastroenterology 148:S-S63. https://doi.org/10.1016/S0016-5085(15)30220-1

  70. Schwitalle Y, Kloor M, Eiermann S, Linnebacher M, Kienle P, Knaebel HP et al (2008) Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 134:988–997. https://doi.org/10.1053/j.gastro.2008.01.015

    Article  CAS  PubMed  Google Scholar 

  71. Shaco-Levy R, Jasperson KW, Martin K, Samadder NJ, Burt RW, Ying J et al (2017) Gastrointestinal polyposis in Cowden syndrome. J Clin Gastroenterol 51:e60–e67. https://doi.org/10.1097/MCG.0000000000000703

    Article  CAS  PubMed  Google Scholar 

  72. Shlien A, Campbell BB, de Borja R, Alexandrov LB, Merico D, Wedge D et al (2015) Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat Genet 47:257–262. https://doi.org/10.1038/ng.3202

    Article  CAS  PubMed  Google Scholar 

  73. Shuen AY, Lanni S, Panigrahi GB, Edwards M, Yu L, Campbell BB et al (2019) Functional repair assay for the diagnosis of constitutional mismatch repair deficiency from non-neoplastic tissue. J Clin Oncol 37:461–470. https://doi.org/10.1200/JCO.18.00474

    Article  CAS  PubMed  Google Scholar 

  74. Sinicrope FA, Sargent DJ (2012) Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications. Clin Cancer Res 18:1506–1512. https://doi.org/10.1158/1078-0432.CCR-11-1469

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. South CD, Hampel H, Comeras I, Westman JA, Frankel WL, de la Chapelle A (2008) The frequency of Muir–Torre syndrome among Lynch syndrome families. JNCI J Natl Cancer Inst 100:277–281. https://doi.org/10.1093/jnci/djm291

    Article  CAS  PubMed  Google Scholar 

  76. Spier I, Holzapfel S, Altmüller J, Zhao B, Horpaopan S, Vogt S et al (2015) Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas. Int J Cancer 137:320–331. https://doi.org/10.1002/ijc.29396

    Article  CAS  PubMed  Google Scholar 

  77. Staal FJT, van der Luijt RB, Baert MRM, van Drunen J, van Bakel H, Peters E et al (2002) A novel germline mutation of PTEN associated with brain tumours of multiple lineages. Br J Cancer 86:1586–1591. https://doi.org/10.1038/sj.bjc.6600206

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Stamos JL, Weis WI (2013) The β-Catenin destruction complex. Cold Spring Harb Perspect Biol 5:a007898. https://doi.org/10.1101/cshperspect.a007898

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Tabori U, Shlien A, Baskin B, Levitt S, Ray P, Alon N et al (2010) TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Oncol 28:1995–2001. https://doi.org/10.1200/JCO.2009.26.8169

    Article  CAS  PubMed  Google Scholar 

  80. Taylor MD, Northcott PA, Korshunov A, Remke M, Cho Y-J, Clifford SC et al (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (Berl) 123:465–472. https://doi.org/10.1007/s00401-011-0922-z

    Article  CAS  Google Scholar 

  81. Therkildsen C, Ladelund S, Rambech E, Persson A, Petersen A, Nilbert M (2015) Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome. Eur J Neurol 22:717–724. https://doi.org/10.1111/ene.12647

    Article  CAS  PubMed  Google Scholar 

  82. Tighe A, Johnson VL, Taylor SS (2004) Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability. J Cell Sci 117:6339–6353. https://doi.org/10.1242/jcs.01556

    Article  CAS  PubMed  Google Scholar 

  83. Turcot J, Despres JP, St Pierre F (1959) Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum 2:465–468

    Article  CAS  PubMed  Google Scholar 

  84. Tutlewska K, Lubinski J, Kurzawski G (2013) Germline deletions in the EPCAM gene as a cause of Lynch syndrome—literature review. Hered Cancer Clin Pract 11:9. https://doi.org/10.1186/1897-4287-11-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ et al (1997) Germ-line mutations of TP53 in Li–Fraumeni families: an extended study of 39 families. Cancer Res 57:3245–3252

    CAS  PubMed  Google Scholar 

  86. Vasen HFA, Ghorbanoghli Z, Bourdeaut F, Cabaret O, Caron O, Duval A et al (2014) Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D” (C4CMMR-D). J Med Genet 51:283–293. https://doi.org/10.1136/jmedgenet-2013-102238

    Article  CAS  PubMed  Google Scholar 

  87. Vasen HFA, Tomlinson I, Castells A (2015) Clinical management of hereditary colorectal cancer syndromes. Nat Rev Gastroenterol Hepatol 12:88–97. https://doi.org/10.1038/nrgastro.2014.229

    Article  PubMed  Google Scholar 

  88. Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H et al (2016) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li–Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol 17:1295–1305. https://doi.org/10.1016/S1470-2045(16)30249-2

    Article  CAS  PubMed  Google Scholar 

  89. Vital A, Bringuier P-P, Huang H, San-Galli F, Rivel J, Ansoborlo S et al (1998) Astrocytomas and choroid plexus tumors in two families with identical p53 germline mutations. J Neuropathol Exp Neurol 57:1061–1069. https://doi.org/10.1097/00005072-199811000-00009

    Article  CAS  PubMed  Google Scholar 

  90. Watson P, Vasen HFA, Mecklin J-P, Bernstein I, Aarnio M, Järvinen HJ et al (2008) The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 123:444–449. https://doi.org/10.1002/ijc.23508

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Wimmer K, Beilken A, Nustede R, Ripperger T, Lamottke B, Ure B et al (2017) A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency. Fam Cancer 16:67–71. https://doi.org/10.1007/s10689-016-9925-1

    Article  CAS  PubMed  Google Scholar 

  92. Wimmer K, Kratz CP, Vasen HFA, Caron O, Colas C, Entz-Werle N et al (2014) Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium “care for CMMRD” (C4CMMRD). J Med Genet 51:355–365. https://doi.org/10.1136/jmedgenet-2014-102284

    Article  CAS  PubMed  Google Scholar 

  93. Wong P, Verselis SJ, Garber JE, Schneider K, DiGianni L, Stockwell DH et al (2006) Prevalence of early onset colorectal cancer in 397 patients with classic Li–Fraumeni syndrome. Gastroenterology 130:73–79. https://doi.org/10.1053/j.gastro.2005.10.014

    Article  PubMed  Google Scholar 

  94. Yakubov E, Ghoochani A, Buslei R, Buchfelder M, Eyüpoglu IY, Savaskan N (2016) Hidden association of Cowden syndrome, PTEN mutation and meningioma frequency. Oncoscience 3:149–155. https://doi.org/10.18632/oncoscience.305

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cynthia Hawkins.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, B., Tabori, U. & Hawkins, C. An update on the CNS manifestations of brain tumor polyposis syndromes. Acta Neuropathol 139, 703–715 (2020). https://doi.org/10.1007/s00401-020-02124-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-020-02124-y

Keywords

Navigation